ArticleBMJ medicine2026
Primary care and community interventions for multimorbidity involving depression or anxiety: systematic review with meta-analysis.
Article in BMJ medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify and characterise primary care or community based interventions for patients with multimorbidity involving depression or anxiety, and to determine their effectiveness for improving patients' mental health, physical health, and quality of life. Design: Systematic review with meta-analysis. Data sources: Medline, Embase, Cochrane Library, CINAHL, PsycInfo, and Web of Science databases, from inception to 11 November 2024. Eligibility criteria for selecting studies: Included studies were randomised controlled trials of primary care or community based interventions targeting adults with depression or anxiety disorders and one or more long term physical conditions. Risk of bias assessment used the Cochrane risk of bias tool. Interventions were categorised as organisational or patient oriented, and were subgrouped by intervention type. Intervention components were systematically categorised, and effects on mental health and quality of life outcomes were meta-analysed in groups defined by intervention type and assessment time point. Physical health outcomes were too heterogenous to meta-analyse and were synthesised without meta-analysis with Fisher's method for combining P values. Results: 29 randomised controlled trials comprising 9487 participants were included. High quality evidence was found for organisational interventions (n=10, including collaborative care, stepped care, and post-discharge interventions) which resulted in small improvements in symptoms of depression (standardised mean difference -0.25, 95% confidence interval (CI) -0.43 to -0.06) and quality of life (0.21, 0.01 to 0.41), but had no effect on symptoms of anxiety at the end of the intervention. No effect on depression or anxiety symptoms was observed, and no data for quality of life were found from organisational interventions at the late follow-up period (18-24 months). In the subgroup analysis, collaborative care resulted in sustained improvements in symptoms of depression at 18-24 months. Synthesis without meta-analysis showed evidence of benefit from organisational interventions (specifically collaborative care) on physiological (eg, haemoglobin A Conclusions: The study showed that interventions improved mental health, physical health, and quality of life outcomes in people with multimorbidity involving depression or anxiety, but the effects were small and, for patient oriented interventions in particular, diminished over time. Systematic review registration: PROSPERO CRD420251004355.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.